Evidence map›Paper›PMID 25755156›Full record

ArticleJournal of the National Cancer Institute2015

Response.

Klaus G Griewank, Rajmohan Murali, André Scherag, Dirk Schadendorf

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Klaus G GriewankDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS); Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY; Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS). klaus.griewank@uk-essen.de dirk.schadendorf@uk-essen.de.
Rajmohan MuraliDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS); Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY; Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS).
André ScheragDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS); Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY; Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS).
Dirk SchadendorfDepartment of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS); Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY; Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationFemaleHumansMaleMelanomaPromoter Regions, GeneticSkin NeoplasmsSunlightTelomeraseX-RaysTelomerase

Identifiers

PMID25755156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.